Osaic Holdings’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Osaic Holdings's MRNA Position: Q2 2026 in Review
Osaic Holdings reduced its Moderna (MRNA) stake by 25% in Q2 2026, selling an estimated $511K and leaving 30,317 shares worth $2.12M. The position accounts for ﹤0.01% of the portfolio, ranked #2255.
Osaic Holdings first reported a position in MRNA in Q1 2020 and has held it in 26 quarters since. The position peaked at $65.1M in Q3 2021. 783 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.
- Osaic Holdings held 30,317 shares of Moderna worth $2.12M as of Q2 2026.
- Osaic Holdings sold 9,880 Moderna shares in Q2 2026, an estimated $511K.
- Moderna made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #2255 holding.
- Osaic Holdings first reported a position in Moderna in Q1 2020 and has held it in 26 quarters since.
- Osaic Holdings's Moderna position peaked at $65.1M in Q3 2021.
- 783 funds tracked by Wall St. Rank held Moderna as of Q2 2026.
Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.